Cullen Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $311M | Sell |
2,037,962
-42,834
| -2% | -$6.57M | 3.19% | 1 |
|
|
2025
Q4 | $287M | Buy |
2,080,796
+10,419
| +0.5% | +$1.36M | 3.13% | 2 |
|
|
2025
Q3 | $266M | Sell |
2,070,377
-26,475
| -1% | -$3.23M | 2.9% | 4 |
|
|
2025
Q2 | $254M | Sell |
2,096,852
-11,832
| -0.6% | -$1.33M | 2.89% | 4 |
|
|
2025
Q1 | $235M | Sell |
2,108,684
-47,935
| -2% | -$5.1M | 2.72% | 7 |
|
|
2024
Q4 | $210M | Sell |
2,156,619
-95,349
| -4% | -$10.2M | 2.44% | 13 |
|
|
2024
Q3 | $259M | Sell |
2,251,968
-618,413
| -22% | -$70.2M | 2.82% | 3 |
|
|
2024
Q2 | $306M | Sell |
2,870,381
-54,043
| -2% | -$5.42M | 3.52% | 2 |
|
|
2024
Q1 | $283M | Buy |
2,924,424
+1,295,186
| +79% | +$133M | 3.15% | 2 |
|
|
2023
Q4 | $165M | Sell |
1,629,238
-1,085,571
| -40% | -$105M | 2.44% | 14 |
|
|
2023
Q3 | $277M | Sell |
2,714,809
-81,081
| -3% | -$8.23M | 3.23% | 1 |
|
|
2023
Q2 | $282M | Sell |
2,795,890
-664,113
| -19% | -$66.4M | 2.52% | 3 |
|
|
2023
Q1 | $318M | Buy |
3,460,003
+672,290
| +24% | +$58.7M | 2.91% | 1 |
|
|
2022
Q4 | $253M | Sell |
2,787,713
-679,560
| -20% | -$57.2M | 3.25% | 1 |
|
|
2022
Q3 | $264M | Buy |
3,467,273
+103,941
| +3% | +$8.62M | 2.82% | 2 |
|
|
2022
Q2 | $284M | Buy |
3,363,332
+68,061
| +2% | +$5.97M | 2.86% | 1 |
|
|
2022
Q1 | $289M | Buy |
3,295,271
+492,643
| +18% | +$42.7M | 2.66% | 2 |
|
|
2021
Q4 | $245M | Sell |
2,802,628
-196,010
| -7% | -$16.3M | 2.3% | 7 |
|
|
2021
Q3 | $245M | Buy |
2,998,638
+131,051
| +5% | +$11.8M | 2.41% | 5 |
|
|
2021
Q2 | $262M | Buy |
2,867,587
+274,919
| +11% | +$24.5M | 2.53% | 3 |
|
|
2021
Q1 | $222M | Buy |
2,592,668
+2,067,642
| +394% | +$186M | 2.39% | 5 |
|
|
2020
Q4 | $49.6M | Sell |
525,026
-119,909
| -19% | -$10.5M | 2.75% | 4 |
|
|
2020
Q3 | $56.1M | Sell |
644,935
-3,665
| -0.6% | -$318K | 3.25% | 3 |
|
|
2020
Q2 | $56.6M | Sell |
648,600
-117,020
| -15% | -$10.1M | 3.19% | 3 |
|
|
2020
Q1 | $63.1M | Sell |
765,620
-51,040
| -6% | -$4.55M | 3.64% | 2 |
|
|
2019
Q4 | $77.3M | Sell |
816,660
-44,966
| -5% | -$4.03M | 3.03% | 3 |
|
|
2019
Q3 | $74.9M | Sell |
861,626
-5,040
| -0.6% | -$453K | 3.01% | 2 |
|
|
2019
Q2 | $79.1M | Sell |
866,666
-106,682
| -11% | -$9.03M | 3.09% | 2 |
|
|
2019
Q1 | $83.9M | Buy |
973,348
+8,397
| +0.9% | +$674K | 3.31% | 1 |
|
|
2018
Q4 | $74.2M | Sell |
964,951
-28,463
| -3% | -$2.22M | 3.2% | 4 |
|
|
2018
Q3 | $76.7M | Sell |
993,414
-6,802
| -0.7% | -$503K | 2.83% | 3 |
|
|
2018
Q2 | $67.7M | Buy |
1,000,216
+3,236
| +0.3% | +$223K | 2.56% | 11 |
|
|
2018
Q1 | $72.2M | Buy |
996,980
+18,141
| +2% | +$1.38M | 2.56% | 8 |
|
|
2017
Q4 | $73.6M | Buy |
978,839
+3,549
| +0.4% | +$268K | 2.53% | 13 |
|
|
2017
Q3 | $75M | Sell |
975,290
-15,708
| -2% | -$1.19M | 2.61% | 12 |
|
|
2017
Q2 | $74.1M | Buy |
990,998
+112,444
| +13% | +$7.97M | 2.61% | 13 |
|
|
2017
Q1 | $58.5M | Sell |
878,554
-19,703
| -2% | -$1.31M | 2.05% | 27 |
|
|
2016
Q4 | $58.6M | Buy |
898,257
+764,917
| +574% | +$49.6M | 2.02% | 27 |
|
|
2016
Q3 | $9.43M | Buy |
133,340
+8,839
| +7% | +$644K | 0.32% | 40 |
|
|
2016
Q2 | $9.21M | Sell |
124,501
-4,040
| -3% | -$279K | 0.32% | 40 |
|
|
2016
Q1 | $8.34M | Buy |
128,541
+1,780
| +1% | +$121K | 0.3% | 39 |
|
|
2015
Q4 | $9.77M | Buy |
126,761
+123
| +0.1% | +$9.77K | 0.33% | 40 |
|
|
2015
Q3 | $10.4M | Sell |
126,638
-9,737
| -7% | -$867K | 0.37% | 40 |
|
|
2015
Q2 | $12M | Sell |
136,375
-20,423
| -13% | -$1.87M | 0.38% | 39 |
|
|
2015
Q1 | $13.9M | Sell |
156,798
-24,664
| -14% | -$2.19M | 0.39% | 41 |
|
|
2014
Q4 | $15.1M | Sell |
181,462
-13,503
| -7% | -$1.12M | 0.41% | 40 |
|
|
2014
Q3 | $16.4M | Sell |
194,965
-335
| -0.2% | -$27.1K | 0.45% | 39 |
|
|
2014
Q2 | $15.8M | Sell |
195,300
-19,474
| -9% | -$1.53M | 0.41% | 38 |
|
|
2014
Q1 | $16.4M | Buy |
214,774
+41,906
| +24% | +$3.05M | 0.44% | 39 |
|
|
2013
Q4 | $12.5M | Buy |
172,868
+1,395
| +0.8% | +$97K | 0.33% | 48 |
|
|
2013
Q3 | $11.8M | Buy |
171,473
+513
| +0.3% | +$33.9K | 0.33% | 45 |
|
|
2013
Q2 | $10.8M | Buy |
+170,960
| New | +$11.1M | 0.33% | 40 |
|
Other funds holding NVS
Cullen Capital Management's NVS Position: Q1 2026 in Review
Cullen Capital Management reduced its Novartis (NVS) stake by 2.1% in Q1 2026, selling an estimated $6.57M and leaving 2,037,962 shares worth $311M. The position accounts for 3.19% of the portfolio, ranked #1.
Cullen Capital Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $318M in Q1 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Cullen Capital Management held 2,037,962 shares of Novartis worth $311M as of Q1 2026.
- Cullen Capital Management sold 42,834 Novartis shares in Q1 2026, an estimated $6.57M.
- Novartis made up 3.19% of Cullen Capital Management's portfolio in Q1 2026, its #1 holding.
- Cullen Capital Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Cullen Capital Management's Novartis position peaked at $318M in Q1 2023.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Cullen Capital Management's 13F filing for Q1 2026, filed 15 May 2026.